Key facts
- AI-Stroke’s last known valuation is $44.1M (Nov 2025).
- It has raised $14.5M; the latest was Seed Round ($14.5M) in Nov 2025.
- Notable investors include Bpifrance, Newfund Management, Boost Invest MedVallée, Business & Innovation Center, Occitanie Invest.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for AI-Stroke
- ·The full record, as it builds
Funding rounds
No funding rounds for AI-Stroke are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AI-Stroke
Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through stroke detection exercises, captures and analyzes video data using a proprietary stroke patient video dataset, enabling healthcare providers to reduce treatment delays, improve diagnosis accuracy, and lower rehabilitation costs.
- Sector
- Healthcare
- HQ
- Montpellier, France
- Founded
- 2022
- Employees
- 7
- Website
- ai-stroke.com/
- Ownership
- Privately Held (backing)
AI-Stroke doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AI-Stroke shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AI-Stroke in its N-PORT filings yet. We sweep new filings monthly.